Pamela Marcus is a Program Director and Epidemiologist in the Healthcare Delivery Research Program's (HDRP) Healthcare Assessment Research Branch (HARB). She is an expert in assessment of cancer screening modalities in both experimental and community settings. She manages grants that address healthcare delivery issues in cancer screening, and is the Project Scientist for the lung component of the second round of the Population-based Research to Optimize the Screening Process (PROSPR) Initiative. Dr. Marcus also is interested in surveillance for disease recurrence among cancer survivors treated with curative intent. She sits on NCI’s PDQ® Screening and Prevention Editorial Board, participates annually in the Preventing Overdiagnosis meetings, and teaches an annual 8-week FAES course on assessment of cancer screening data.
Dr. Marcus began her career at NCI as a postdoctoral Cancer Prevention Fellow. From 1997 to 2011, she was a member of the Division of Cancer Prevention's Biometry Research Group. She was Lead Epidemiologist for the NCI component of the National Lung Screening Trial and published on operational aspects of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Dr. Marcus moved to the Applied Research Program (ARP) in NCI's Division of Cancer Control and Population Sciences (DCCPS) in 2011, and joined DCCPS’s Epidemiology and Genomics Research Program (EGRP) in 2013. During those years, she continued to manage cancer screening initiatives, including the Research Resource of the Breast Cancer Surveillance Consortium (BCSC), and explored emerging issues in cancer screening, such as risk-stratified screening.
Dr. Marcus received a PhD in Epidemiology from the University of North Carolina, Chapel Hill and an MS in Preventive Medicine and in Statistics from the University of Wisconsin–Madison.